Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Telotristat Etiprate PK in Healthy Subjects
NCT02157584Phase 1Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jun 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telotristat ethyl in Carcinoid Syndrome (CS) (2 arms), sponsored by Lexicon Pharmaceuticals, Inc. Primary endpoints: Plasma concentrations of telotristat ethyl at Day 8 and Plasma concentration of metabolite LP-778902 at Day 8. Started Jun 2014; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on NCT02157584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157584.